Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study
International Journal of Urology · 2023-06 · 30 (6) · 547-553
DOI: 10.1111/iju.15178 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 20.03.2023. Verfasst von Katsuyoshi Hashine und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Robotic Surgical Procedures. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objectives
The use of radical prostatectomy is increasing with the rising incidence of prostate cancer. We assessed the surgical trends related to radical prostatectomy using data from a multi‐center, retrospective cohort study, the MICAN (Medical Investigation Cancer Network) study, which was conducted in all the urology‐related medical facilities in Ehime Prefecture, Japan.
Methods
We compared data from the MICAN study with prostate biopsy registry data collected in Ehime between 2010 and 2020 and recorded the surgical trends.
Results
There was a significant increase in the mean age of patients with positive biopsies, and the positivity rate increased from 46.3% in 2010 to 60.5% in 2020, while the number of biopsies obtained decreased. The number of radical prostatectomies performed increased over the years, with robot‐assisted radical prostatectomy becoming the predominant procedure. In 2020, robot‐assisted radical prostatectomies accounted for 96.0% of the surgeries performed. The age at surgery also gradually increased. Of the registered patients aged ≤75 years, 40.5% underwent surgery in 2010, compared with 83.1% in 2020. The prevalence of surgery also increased from 4.6% to 29.8% in patients aged >75 years. There was a gradual increase in the proportion of high‐risk cases, from 29.3% to 44.0%, but a decrease in that of low‐risk cases, from 23.8% in 2010 to 11.4% in 2020.
Conclusions
We have shown that the number of radical prostatectomies performed in Ehime is increasing in patients aged both ≤75 and >75 years. The proportion of low‐risk cases has decreased, while that of high‐risk cases has increased.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
- Division of Clinical Biostatistics, Section of Cancer Prevention and Epidemiology, Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
- Department of Urology, Matsuyama Red Cross Hospital, Matsuyama, Japan.
- Department of Urology, Ehime Prefectural Central Hospital, Matsuyama, Japan.
- Department of Urology, Sumitomo Besshi Hospital, Niihama, Japan.
- Department of Urology, Uwajima City Hospital, Uwajima, Japan.
ORCID-Profile: Takashi Saika
Zitieren
APA
Hashine, K., Yamashita, N., Tachou, T., Kan, M., Yanagaki, T., Oka, A., Takeda, H., Shirato, A., Watanabe, U., Miura, N., & Saika, T. (2023). Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study. International Journal of Urology, 30(6), 547-553. https://doi.org/10.1111/iju.15178
Vancouver
Hashine K, Yamashita N, Tachou T, Kan M, Yanagaki T, Oka A, et al. Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study. International Journal of Urology. 2023;30(6):547-553. doi:10.1111/iju.15178
BibTeX
@article{Hashine2023,
author = {Hashine, Katsuyoshi and Yamashita, Natsumi and Tachou, Takatoshi and Kan, Masaharu and Yanagaki, Takahiro and Oka, Akihiro and Takeda, Hajime and Shirato, Akitomi and Watanabe, Uichi and Miura, Noriyoshi and Saika, Takashi},
title = {Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study},
journal = {International Journal of Urology},
year = {2023},
volume = {30},
number = {6},
pages = {547--553},
doi = {10.1111/iju.15178}
}
EUVIMED